Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 18382 | eCF506 ( NXP 900 ) | 1914078-41-3 | ≧98.0% |  |
| eCF506 targets a molecule called Src tyrosine kinase that is required for breast canc | ||||
| 1710121 | Esaxerenone | 1632006-28-0 | >98% |  |
| Esaxerenone (INN) (developmental code names CS-3150, XL-550) is a nonsteroidal antimi | ||||
| 179831 | EBE-A22 | 229476-53-3 | 98.0% |  |
| EBE-A22 is a derivative of PD 153035. EBE-A22, has no effect on EGF-R TK but maintain | ||||
| 011309 | EPZ015666 | 1616391-65-1 | 98% |  |
| EPZ015666 is a potent, selective and orally bioavailable PRMT5 inhibitor with Ki of 5 | ||||
| 178311 | EED226 | 2083627-02-3 | 98.0% |  |
| EED226 is a potent, selective, and orally bioavailable EED inhibitor. induces robust | ||||
| 651701 | Erdafitinib(JNJ-42756493) | 1346242-81-6 | 98% Min. | -cas-1346242-81-6.png) |
| Erdafitinib(JNJ-42756493)is a potent and selective orally bioavailable, pan fibroblas | ||||
| 178157 | Ethyl 2-cyclohexyl-2-oxoacetate | 13275-31-5 | 96.0% |  |
| Ethyl 2-cyclohexyl-2-oxoacetate | ||||
| 178903 | E7449 | 1140964-99-3 | 98.0% |  |
| E7449 is an orally available small molecule inhibitor of the nuclear enzymes poly (AD | ||||
| 2017878 | Elenbecestat ( E2609 ) | 1388651-30-6 | ≧98.0% | _1388651-30-6.png) |
| Elenbecestat (E2609) is a potent, orally bioavailable and CNS-penetrant BACE-1 inhibi | ||||
| 20178213 | Etoposide Phosphate | 117091-64-2 | 98.0% |  |
| Etoposide phosphate is a phosphate salt of a semisynthetic derivative of podophylloto | ||||
| 20178210 | Elamipretide | 736992-21-5 | 98% |  |
| Elamipretide, also known as MTP-131 or D-Arg-Dmt-Lys-Phe-NH2,is a cardiolipin peroxid | ||||
| 20177314 | erythro-N-Boc-L-3,5-difluorophenylalanine epoxide | 388071-27-0 | 98.0% |  |
| ERYTHRO-N-BOC-L-3,5-DIFLUOROPHENYLALANINE EPOXIDE | ||||
| 17031018 | Etrasimod | 1206123-37-6 | 99.73% |  |
| Etrasimod ( APD334 ) is a potent, once-daily, oral, highly selective sphingosine 1-ph | ||||
| 17031010 | eFT-508 | 1849590-01-7 | 98% | |
| eFT-508 (eFT508) is a potent and selective MNK1/2 inhibitor, potentially resulting | ||||
| 17022806 | Epetraborole hydrochloride | 1234563-16-6 | 98% | |
| Epetraborole hydrochloride is a novel leucyl-tRNA synthetase (LeuRS) inhibitor. | ||||
| 17022718 | Eliglustat | 491833-29-5 | 98% |  |
| Eliglustat, also known as Genz-112638, is is a potent and selective glucosylceramide | ||||
| 17011802 | EX-527 S-enantiomer | 848193-68-0 | 98% |  |
| EX-527 S-enantiomer is a potent and selective SIRT1 inhibitor with IC50 of 123 nM; no | ||||
| 17011801 | EX-527 R-enantiomer | 848193-69-1 | 98% |  |
| EX-527 R-enantiomer is a negative control of the active form EX-527 S-enantiomer(Spec | ||||
| 17011301 | 4E1RCat | 328998-25-0 | 98% |  |
| 4E1RCat is an inhibitor of the eIF4F translation initiation complex that blocks eIF4E | ||||
| 17011103 | Etomoxir (Na salt) | 828934-41-4 | 98% | |
| Etomoxir is an irreversible inhibitor of carnitine palmitoyltransferase-1 (CPT-1) o | ||||
| 711401 | Eganelisib ( IPI-549 ) | 1693758-51-8 | ≧98.0% |  |
| Eganelisib (IPI-549) is a first-in-class, orally administered, highly selective PI3Kγ | ||||
| 16122944 | Ezutromid | 945531-77-1 | 98% |  |
| Ezutromid, also known as BMN-195 and SMTC-1100, is a first orally bioavailable utroph | ||||
| 16122943 | EXP-3174 | 124750-92-1 | 98% |  |
| EXP-3174, also known as Losartan Carboxylic Acid, is a physiologically active metabol | ||||
| 16122942 | Ertiprotafib | 251303-04-5 | 98% |  |
| Ertiprotafib, also known as PTP-112, is a Protein Tyrosine Phosphatase 1B Inhibitor ( | ||||
| 16122941 | Eptapirone | 179756-85-5 | 98% | |
| Eptapirone, also known as F11440, is a potent, selective, high efficacy 5-HT1A recept | ||||
| 16122940 | Eprodisate Sodium | 36589-58-9 | 98% |  |
| Eprodisate, also known as 3-PDS; NC-503; 3PDS, is an orally available disodium salt f | ||||
| 16122939 | Emeramide ( BDTH2 ) | 351994-94-0 | ≧98.0% | _351994-94-0.png) |
| Emeramide, also known as BDTH2, is a mercury and heavy metal chelator. BDTH2 molecule | ||||
| 16122938 | EMD534085 | 858668-07-2 | 98% |  |
| EMD534085 is a kinesin inhibitor currently in clinical development. | ||||
| 16122811 | Ellipticine | 519-23-3 | 98% |  |
| Ellipticine is a DNA intercalating agent and a DNA topoisomerase II inhibitor. Ellipt | ||||
| 16122810 | Elacestrant dihydrochloride | 1349723-93-8 | ≧98.0% |  |
| Elacestrant dihydrochloride, also known as RAD1901, is an orally available, selective | ||||